Mirae Asset Global Investments Co. Ltd. Buys 5,986 Shares of HCA Healthcare, Inc. (NYSE:HCA)

Mirae Asset Global Investments Co. Ltd. lifted its holdings in HCA Healthcare, Inc. (NYSE:HCAGet Rating) by 34.4% in the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 23,395 shares of the company’s stock after acquiring an additional 5,986 shares during the period. Mirae Asset Global Investments Co. Ltd.’s holdings in HCA Healthcare were worth $5,864,000 as of its most recent filing with the Securities and Exchange Commission.

Other hedge funds have also recently made changes to their positions in the company. Mount Yale Investment Advisors LLC boosted its stake in HCA Healthcare by 5.3% during the 1st quarter. Mount Yale Investment Advisors LLC now owns 5,178 shares of the company’s stock valued at $1,298,000 after purchasing an additional 259 shares during the last quarter. CI Investments Inc. boosted its stake in HCA Healthcare by 51.6% during the 1st quarter. CI Investments Inc. now owns 18,788 shares of the company’s stock valued at $4,709,000 after purchasing an additional 6,392 shares during the last quarter. CVA Family Office LLC boosted its stake in shares of HCA Healthcare by 31.5% in the 1st quarter. CVA Family Office LLC now owns 605 shares of the company’s stock worth $152,000 after buying an additional 145 shares during the last quarter. Commerce Bank boosted its position in HCA Healthcare by 6.1% in the fourth quarter. Commerce Bank now owns 6,859 shares of the company’s stock worth $1,762,000 after purchasing an additional 392 shares during the last quarter. Finally, Machina Capital S.A.S. purchased a new position in HCA Healthcare in the first quarter worth $226,000. 65.75% of the stock is owned by institutional investors.

Insider Transactions at HCA Healthcare

In other news, major shareholder Patricia F. Elcan bought 325 shares of the firm’s stock in a transaction dated Monday, July 25th. The stock was purchased at an average price of $198.66 per share, with a total value of $64,564.50. Following the transaction, the insider now owns 89,337 shares of the company’s stock, valued at $17,747,688.42. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink. Corporate insiders own 1.50% of the company’s stock.

HCA Healthcare Trading Down 2.4 %

Shares of HCA stock opened at $194.06 on Friday. The stock has a market capitalization of $55.70 billion, a PE ratio of 9.33, a P/E/G ratio of 1.53 and a beta of 1.72. HCA Healthcare, Inc. has a 1-year low of $164.47 and a 1-year high of $279.02. The business has a 50-day moving average of $205.76 and a 200 day moving average of $214.90. The company has a debt-to-equity ratio of 87.46, a current ratio of 1.55 and a quick ratio of 1.32.

HCA Healthcare (NYSE:HCAGet Rating) last released its quarterly earnings data on Friday, July 22nd. The company reported $4.21 earnings per share for the quarter, topping the consensus estimate of $3.67 by $0.54. HCA Healthcare had a return on equity of 833.68% and a net margin of 10.83%. The business had revenue of $14.82 billion during the quarter, compared to analysts’ expectations of $14.73 billion. During the same quarter last year, the business posted $4.37 EPS. The business’s revenue was up 2.7% on a year-over-year basis. As a group, sell-side analysts anticipate that HCA Healthcare, Inc. will post 17.09 earnings per share for the current year.

HCA Healthcare Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, September 30th. Stockholders of record on Friday, September 16th will be given a $0.56 dividend. This represents a $2.24 annualized dividend and a dividend yield of 1.15%. The ex-dividend date of this dividend is Thursday, September 15th. HCA Healthcare’s dividend payout ratio is currently 10.77%.

Analyst Upgrades and Downgrades

Several analysts have issued reports on HCA shares. Oppenheimer set a $255.00 target price on HCA Healthcare in a research note on Monday, June 20th. Loop Capital assumed coverage on HCA Healthcare in a research note on Thursday, June 16th. They set a “buy” rating and a $240.00 price objective on the stock. SVB Leerink boosted their price objective on HCA Healthcare from $240.00 to $259.00 and gave the company an “outperform” rating in a research note on Wednesday, August 24th. Royal Bank of Canada decreased their price objective on HCA Healthcare from $267.00 to $256.00 and set an “outperform” rating on the stock in a research note on Tuesday, June 21st. Finally, Bank of America boosted their price objective on HCA Healthcare from $192.00 to $230.00 in a research note on Sunday, July 24th. One equities research analyst has rated the stock with a sell rating, three have assigned a hold rating and sixteen have given a buy rating to the company. According to data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and an average price target of $239.14.

HCA Healthcare Profile

(Get Rating)

HCA Healthcare, Inc, through its subsidiaries, provides health care services company in the United States. The company operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.

Recommended Stories

Want to see what other hedge funds are holding HCA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HCA Healthcare, Inc. (NYSE:HCAGet Rating).

Institutional Ownership by Quarter for HCA Healthcare (NYSE:HCA)

Receive News & Ratings for HCA Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.